Novartis, which was widely tipped to snap up Nestle's stake as soon as its option allowed, also aims to buy out the 23 percent held by minority shareholders for $11.2 billion, ending uncertainty over whether or not it would seek full control.
Emma Thomasson
Advertisement
Articles by Emma Thomasson
Advertisement
Latest Updated Articles
Novartis Seeks to Buy Rest of Alcon for $39 BillionPublished: January 11th 2010 | Updated:
Advertisement
Advertisement
Trending on Medical Economics
1
‘Physician associate’ title gains momentum across state legislatures
2
GE HealthCare reports Q3 revenue growth, raises earnings guidance amid tariff headwinds
3
Physicians who use AI face a ‘competence penalty,’ Johns Hopkins study finds
4
Breaking point: Solving the health industry’s financial and human capacity crisis
5
